Seres Therapeutics Inc (MCRB) Insider Trading
- $47,525,463.45
- $53,501,557.66
- Nov. 18, 2024
- Roger Pomerantz
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 30, 2016 | CFO | 4,533 | $29.54 | Sell | $133,904.82 | |
| June 28, 2016 | CFO | 5,001 | $28.28 | Sell | $141,428.28 | |
| June 27, 2016 | EVP | 9,390 | $27.23 | Sell | $255,689.70 | |
| June 2, 2016 | CEO | 74,049 | $32.52 | Sell | $2,408,073.48 | |
| June 2, 2016 | EVP | 8,000 | $31.00 | Sell | $248,000.00 | |
| June 1, 2016 | EVP | 16,000 | $29.43 | Sell | $470,880.00 | |
| June 1, 2016 | CEO | 70,951 | $30.51 | Sell | $2,164,715.01 | |
| May 25, 2016 | Major Shareholder | 1,000,000 | $27.60 | Sell | $27,600,000.00 | |
| May 24, 2016 | CEO | 9,801 | $30.00 | Sell | $294,030.00 | |
| May 6, 2016 | CEO | 8,507 | $24.31 | Sell | $206,805.17 | |
| May 5, 2016 | CEO | 59,325 | $26.13 | Sell | $1,550,162.25 | |
| May 3, 2016 | CEO | 67,367 | $28.70 | Sell | $1,933,432.90 | |
| April 25, 2016 | EVP | 18,640 | $31.94 | Sell | $595,361.60 | |
| April 7, 2016 | CEO | 9,212 | $30.00 | Sell | $276,360.00 | |
| April 7, 2016 | EVP | 8,000 | $31.00 | Sell | $248,000.00 | |
| April 4, 2016 | CEO | 135,788 | $27.20 | Sell | $3,693,433.60 | |
| April 4, 2016 | CFO | 6,568 | $28.85 | Sell | $189,486.80 | |
| April 4, 2016 | EVP | 61,000 | $26.16 | Sell | $1,595,760.00 | |
| March 31, 2016 | CFO | 7,663 | $26.30 | Sell | $201,536.90 | |
| March 28, 2016 | EVP | 9,390 | $23.89 | Sell | $224,327.10 | |
| March 28, 2016 | CFO | 5,473 | $24.07 | Sell | $131,735.11 |
Insiders are both buying and selling Seres Therapeutics Inc stock.
The insider traders at Seres Therapeutics Inc are: Roger Pomerantz, Eric D Shaff, John G Aunins, Thomas Desrosier, David N Cook, Moltke Lisa Von, David Arkowitz, David S Ege, Michele Trucksis, Teresa L Young, Paula Cloghessy, Marcus Chapman, Ventures Fund 2007 L Flagship, Health Ltp Fund Ge Nutritional, and Noubar Afeyan
The most active insider trader at Seres Therapeutics Inc is Roger Pomerantz with 19 trades.
Ventures Fund 2007 L Flagship has sold the most Seres Therapeutics Inc stock with a total value of $55,200,000.00.
Health Ltp Fund Ge Nutritional has bought the most Seres Therapeutics Inc stock with a total value of $55,050,930.90.
The most recent insider trade for Seres Therapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Seres Therapeutics Inc was from Health Ltp Fund Ge Nutritional with a total value of $27,525,465.45 on July 5, 2022.
The single biggest insider sell for Seres Therapeutics Inc was from Ventures Fund 2007 L Flagship with a total value of $27,600,000.00 on May 25, 2016.